TL;DR
- •College and graduate students have among the highest mental-health prevalence in any age cohort — roughly 1 in 3 report a major depressive or anxiety disorder, and demand for campus counseling services has outstripped supply for years.
- •Graduate and professional school populations face additional stressors: financial debt, isolated work, competitive evaluation, often without a clear social safety net.
- •Telehealth ketamine therapy fits student schedules — sessions evenings or weekends, no clinic waiting rooms, completely private from any university health system or transcript record.
- •Tovani is direct-pay ($349/month, HSA/FSA eligible) — bypasses any student insurance record. Treatment is not disclosed to schools or visible on academic records.
- •For treatment-resistant depression — common in students who've already tried multiple SSRIs through campus counseling — ketamine's rapid mechanism can produce noticeable change within days, useful when long therapy timelines aren't feasible during a degree program.
- •Most student-patients say what mattered most was: bypassing the campus counseling waitlist; treatment that fits around exams and deadlines; complete separation from their university health record.
The stressors specific to your work
- •Academic pressure layered with financial stress (loans, opportunity cost)
- •Isolation — many graduate programs are solo research environments
- •Identity-defining evaluations (comprehensive exams, board exams, dissertation defenses)
- •First-generation students often lack the family support networks others rely on
- •Imposter syndrome amplified by competitive cohort dynamics
- •Limited time for self-care during peak semester intensity
Why telehealth works for students
- •No clinic visits — fits between classes, labs, and library time
- •Sessions scheduled around exam windows and submission deadlines
- •Treatment in your dorm, apartment, or home — completely private
- •Same physician every visit — no rotating campus counselor panel
- •Works across study-abroad or summer-research locations within FL/NJ
Privacy considerations
- •Tovani is direct-pay — no insurance claim tied to student health plan
- •Patient records are NEVER visible to your university, dean of students, advisor, or academic department
- •Mental health treatment is not part of academic records and does not affect transcripts, recommendations, or fellowship applications
- •Even when students disclose mental-health treatment for accommodations (extended-time exams, etc.), the underlying records remain private
5-minute screening · Reviewed by a board-certified physician · FL & NJ · $349/month
Frequently asked
Will my university find out?
No. Tovani is a private medical practice with HIPAA protections — your school, advisor, department, and dean of students have no access to your records. Treatment doesn't appear on transcripts, doesn't affect academic standing, and isn't reported to any school-affiliated database.
I already tried 3 SSRIs through campus counseling. Is ketamine right?
Possibly. Multiple SSRI/SNRI failures with persistent symptoms is the strongest case for ketamine in the medical literature. The mechanism (NMDA/glutamate) is different from serotonin-focused antidepressants, so prior medication failures don't predict ketamine response. About 60-70% of treatment-resistant patients respond to ketamine in controlled studies.
How will this fit my exam / dissertation schedule?
Treatment is flexible. Most patients do an initial intensive phase (4-6 sessions over 2-4 weeks) followed by monthly maintenance. Sessions are 1-2 hours total including recovery. Many students plan the initial phase during reading week or after exams, then transition to maintenance during regular semester. Your physician will help time it.
Will this affect my driving / studying / cognition?
Dissociative effects last only during the dosing window (1-2 hours) plus a brief recovery period — by the next day you're fully back to baseline. Many student-patients report IMPROVED concentration and motivation within weeks of starting treatment, particularly when depression has been impairing cognition.
What about medical / dental / law school students concerned about board licensure?
Licensure board questions vary by state and program. Most states' professional licensure applications ask about CURRENT mental health conditions that impair fitness to practice, NOT about whether you've ever received mental health treatment. Standard outpatient depression / anxiety treatment that you're managing successfully typically doesn't require disclosure or affect licensure. Discuss specifics with student affairs or a board representative if you have concerns.
References
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT in treatment-resistant depression — relevant for student populations who've cycled through multiple SSRIs via campus counseling without sufficient response. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine's rapid-action mechanism — particularly relevant when timeline-constrained patients (exam schedules, dissertation deadlines) need faster response than SSRIs typically provide. PMID 28249076